| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-06 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-06 |
| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-06 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
9e-06 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
| mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
| mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
2e-05 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |